Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib

被引：0
|
作者：
Hua Cheng
She-Juan An
Song Dong
Yi-Fang Zhang
Xu-Chao Zhang
Zhi-Hong Chen
Yi-Long Jian-Su
机构：
[1] Guangdong Lung Cancer Institute; Medical Research Center of Guangdong General Hospital & Guangdong Academy of Medical Sciences,
[2] Thoracic oncology,undefined
[3] the fifth affiliated hospital of Sun Yat-Sen university,undefined
来源：
Journal of Hematology & Oncology | / 4卷
关键词：
Paclitaxel; Gefitinib; Erlotinib; H1650 Cell; Combination Index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines
    Effendi, Wiwin Is
    Nagano, Tatsuya
    Tachihara, Motoko
    Umezawa, Kanoko
    Kiriu, Tatsunori
    Dokuni, Ryota
    Katsurada, Masahiro
    Yamamoto, Masatsugu
    Kobayashi, Kazuyuki
    Nishimura, Yoshihiro
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3669 - 3679
  • [42] The BIM Deletion Polymorphism in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors
    Lee, Ji Yun
    Ku, Bo Mi
    Lim, Sung Hee
    Kim, Haesu
    Yoo, Kwai Han
    Jung, Ki Sun
    Song, Haa-Na
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S580 - S580
  • [43] Gefitinib first or gefitinib second -: Is timing everything in the treatment of EGFR mutant non-small cell lung cancer?
    Jaenne, Pasi A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (08) : 783 - 785
  • [44] Is CD73 Expression a Druggable Mechanism of Resistance in EGFR-TKI-Treated EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)?
    Eide, I. J.
    Dyrbekk, A. P.
    Helland, A.
    Ekman, S.
    Koivunen, J.
    Cicenas, S.
    Gronberg, B.
    Bisha, I.
    Haberichter, T.
    Lakis, S.
    Chan, J.
    Lewis, A.
    Martin, P.
    Cooper, Z.
    Brustugun, O. T.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1154 - S1154
  • [45] Schedule-dependent apoptosis in k-ras mutant non-small-cell lung cancer cell lines treated with docetaxel and erlotinib:: Rationale for pharmacodynamic separation
    Mahaffey, Christopher M.
    Davies, Angela M.
    Lara, Primo N., Jr.
    Pryde, Brandi
    Holland, William
    Mack, Philip C.
    Gumerlock, Paul H.
    Gandara, David R.
    CLINICAL LUNG CANCER, 2007, 8 (09) : 548 - 553
  • [46] Schedule-dependent cytotoxicity of sunitinib and TRAIL in human non-small cell lung cancer cells with or without EGFR and KRAS mutations
    Bao, Yong-Xia
    Zhao, Xiao-Dan
    Deng, Hong-Bin
    Lu, Chang-Lian
    Guo, Yang
    Lu, Xing
    Deng, Li-Li
    CELLULAR ONCOLOGY, 2016, 39 (04) : 343 - 352
  • [47] Role of FBXW7 in the quiescence of gefitinib-resistant lung cancer stem cells in EGFR-mutant non-small cell lung cancer
    Hidayat, Moulid
    Mitsuishi, Yoichiro
    Takahashi, Fumiyuki
    Tajima, Ken
    Yae, Toshifumi
    Miyahara, Katsumi
    Hayakawa, Daisuke
    Winardi, Wira
    Ihara, Hiroaki
    Koinuma, Yoshika
    Wirawan, Aditya
    Nurwidya, Fariz
    Kato, Motoyasu
    Kobayashi, Isao
    Sasaki, Shinichi
    Takamochi, Kazuya
    Hayashi, Takuo
    Suehara, Yoshiyuki
    Moriyama, Mariko
    Moriyama, Hiroyuki
    Habu, Sonoko
    Takahashi, Kazuhisa
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2019, 19 (04) : 355 - 367
  • [48] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
    Gen, Soei
    Tanaka, Ichidai
    Morise, Masahiro
    Koyama, Junji
    Kodama, Yuta
    Matsui, Akira
    Miyazawa, Ayako
    Hase, Tetsunari
    Hibino, Yoshitaka
    Yokoyama, Toshihiko
    Kimura, Tomoki
    Yoshida, Norio
    Sato, Mitsuo
    Hashimoto, Naozumi
    BMC CANCER, 2022, 22 (01)
  • [49] Weight loss in patients on osimertinib for metastatic EGFR-mutant non-small cell lung cancer
    Chen, Lanyi Nora
    Ma, Xin
    Herzberg, Benjamin
    Henick, Brian S.
    Biswas, Anup K.
    Acharyya, Swarnali
    Shu, Catherine A.
    ONCOLOGIST, 2024,
  • [50] Selective Antitumor Activity of Ibrutinib in EGFR-Mutant Non-Small Cell Lung Cancer Cells
    Gao, Wen
    Wang, Michael
    Wang, Li
    Lu, Haibo
    Wu, Shuhong
    Dai, Bingbing
    Ou, Zhishuo
    Zhang, Liang
    Heymach, John V.
    Gold, Kathryn A.
    Minna, John
    Roth, Jack A.
    Hofstetter, Wayne L.
    Swisher, Stephen G.
    Fang, Bingliang
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (09):
12345